VBA
HAE icon

Van Berkom & Associates’s Haemonetics HAE Stock Holding History

Van Berkom & Associates’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-973,593
Closed -$56.5M – 64
2017
Q4 		$56.5M Sell
973,593
-228,633
-19% -$12M 1.84% 33
2017
Q3 		$53.9M Sell
1,202,226
-3,610
-0.3% -$150K 1.94% 28
2017
Q2 		$47.6M Buy
1,205,836
+63,235
+6% +$2.6M 1.73% 34
2017
Q1 		$46.4M Buy
1,142,601
+5,630
+0.5% +$220K 1.74% 34
2016
Q4 		$45.7M Sell
1,136,971
-267,084
-19% -$10.1M 1.83% 35
2016
Q3 		$50.8M Sell
1,404,055
-122,670
-8% -$4.21M 2.16% 22
2016
Q2 		$44.3M Buy
1,526,725
+224,655
+17% +$6.79M 2.02% 28
2016
Q1 		$45.5M Buy
1,302,070
+11,507
+0.9% +$372K 2.07% 29
2015
Q4 		$41.6M Sell
1,290,563
-3,240
-0.3% -$105K 2.06% 26
2015
Q3 		$41.8M Buy
1,293,803
+70,670
+6% +$2.66M 2.09% 25
2015
Q2 		$50.6M Sell
1,223,133
-28,350
-2% -$1.2M 2.39% 11
2015
Q1 		$56.2M Sell
1,251,483
-99,914
-7% -$4.18M 2.55% 9
2014
Q4 		$50.6M Sell
1,351,397
-42,426
-3% -$1.55M 2.44% 12
2014
Q3 		$48.7M Buy
1,393,823
+47,554
+4% +$1.7M 2.43% 13
2014
Q2 		$47.5M Buy
1,346,269
+87,947
+7% +$2.94M 2.59% 13
2014
Q1 		$41M Buy
1,258,322
+350,527
+39% +$13.4M 2.31% 19
2013
Q4 		$38.2M Buy
+907,795
New +$37.4M 2.14% 26

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Van Berkom & Associates's HAE Position: Q1 2018 in Review

Van Berkom & Associates sold out of Haemonetics (HAE) in Q1 2018, closing a stake of 973,593 shares — an estimated $56.5M sold.

Van Berkom & Associates first reported a position in HAE in Q4 2013 and held it in 17 quarters. The position peaked at $56.5M in Q4 2017. 261 funds tracked by Wall St. Rank hold HAE as of Q1 2018.

  • Van Berkom & Associates reported no remaining Haemonetics position as of Q1 2018 after selling out during the quarter.
  • Van Berkom & Associates sold 973,593 Haemonetics shares in Q1 2018, an estimated $56.5M.
  • Van Berkom & Associates first reported a position in Haemonetics in Q4 2013 and held it in 17 quarters.
  • Van Berkom & Associates's Haemonetics position peaked at $56.5M in Q4 2017.
  • 261 funds tracked by Wall St. Rank held Haemonetics as of Q1 2018.

Based on Van Berkom & Associates's 13F filing for Q1 2018, filed 8 May 2018.